⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27228679 | 1.00 | — | — | |
| SCHEMBL6291929 | 1.00 | — | — | |
| SCHEMBL27228466 | 0.84 | — | — | |
| SCHEMBL1302948 | 0.84 | — | — | |
| SCHEMBL298754 | 0.84 | — | — | |
| SCHEMBL27228471 | 0.82 | GSR (0.64) | — | |
| SCHEMBL602426 | 0.82 | GSR (0.68) | — | |
| SCHEMBL8068164 | 0.82 | GSR (0.68) | — | |
| Hydrochloric Acid SCHEMBL11780148 | 0.79 | GSR (0.65) | — | |
| SCHEMBL1763869 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240173309-A1 | LIPIDATED PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR | JANSSEN RESEARCH & DEVELOPMENT, LLC | 2024-05-30 | — | — | US | disclosed |
| CN-103819403-B | For treating the disease relevant with fluid retention or salt over loading and the Compounds and methods for of disorder of gastrointestinal tract | 阿德利克斯公司 | 2017-01-04 | — | — | CN | disclosed |
| CN-104370888-A | Neuroprotective effect compound and preparation method and use thereof | HAN BING | 2015-02-25 | — | — | CN | disclosed |
| CN-104370889-A | Intraocular tension reducing compound and preparation method and use thereof | HAN BING | 2015-02-25 | — | — | CN | disclosed |
| CN-104370897-A | Protease inhibitor and preparing method and use thereof | HAN BING | 2015-02-25 | — | — | CN | disclosed |
| CN-103819403-A | Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders | ARDELYX INC | 2014-05-28 | — | — | CN | disclosed |
| CN-102333759-A | Compounds and methods for inhibiting NHE-mediated antiport for the treatment of disorders associated with fluid retention or salt overload and gastrointestinal disorders | ARDELYX INC | 2012-01-25 | — | — | CN | disclosed |
| CN-102304075-A | Inhibitors of viral replication | INTERMUNE INC | 2012-01-04 | — | — | CN | disclosed |
| CN-101918371-A | Amide derivatives as sirtuin modulators | SIRTRIS PHARMACEUTICALS INC | 2010-12-15 | — | — | CN | disclosed |
| CN-101304976-A | Inhibitors of viral replication | INTERMUNE INC (US) | 2008-11-12 | — | — | CN | disclosed |